No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/grapherence/d1314901.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/grapherence/d1314901. Accessed May 7, 2024.
No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/grapherence/d1314901
No Net Benefit for Ticagrelor Plus Aspirin Over Aspirin Alone in Patients With T2DM and Stable Coronary Disease [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 May 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/grapherence/d1314901.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - No net benefit for ticagrelor plus aspirin over aspirin alone in patients with T2DM and stable coronary disease
ID - 1314901
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314901/all/grapherence/d1314901
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -